Prognostic impact of peripheral artery disease in patients with and without high bleeding risk undergoing percutaneous coronary intervention.
Alessandro SpiritoRebecca CohenSamantha SartoriBirgit VogelUsman BaberBrunna PileggiKenneth SmithDanielle NicosiaKarim KamaleldinSerdar FarhanAnnapoorna S KiniSamin K SharmaGeorge D DangasRoxana MehranPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2024)
At 1-year after PCI, PAD was associated with increased 1-year risks of MACE in HBR patients. After adjustment for cardiovascular risk factors and comorbidities, the effect of PAD on adverse events was largely attenuated.
Keyphrases
- cardiovascular risk factors
- percutaneous coronary intervention
- peripheral artery disease
- end stage renal disease
- acute myocardial infarction
- acute coronary syndrome
- coronary artery disease
- st segment elevation myocardial infarction
- atrial fibrillation
- ejection fraction
- st elevation myocardial infarction
- antiplatelet therapy
- newly diagnosed
- chronic kidney disease
- cardiovascular disease
- coronary artery bypass grafting
- peritoneal dialysis
- metabolic syndrome
- human health
- coronary artery bypass
- patient reported